Navigating IRA Price Controls: Implications for Pharmacy and Outcomes' Role

With the passage of the Inflation Reduction Act (IRA), the pharmaceutical and healthcare landscapes are facing unprecedented regulatory changes. Among the most impactful are the new federal drug price negotiation provisions, which are poised to reshape pharmacy operations, prescribing patterns, and the broader health outcomes ecosystem.

Join us for an in-depth webinar, "Navigating IRA Price Controls: Implications for Pharmacy and Outcomes’ Role," where Jon Grice PharmD, MSA will unpack the evolving policy landscape and explore its implications across the pharmacy landscape.